use of katphaladi churna in tamaka shwasa w.s.r. to bronchial asthama

Open labeled, active controlled, randomized, comparative clinical evaluation of efficacy and safety of Katphaladi Churna in Tamaka Shwasa with special reference to Bronchial Asthma -

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041707

Enrollment

Registered

2022-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J041- Acute tracheitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Intermittent and mild persistent cases of asthma. 1. Symptoms/exacerbation (wheeze, cough and breathlessness) 2 days/week but not daily. 2. Night time awakening 4 times/month. 3. Asthmatics who meet reversibility criteria [15% improvement in PEFR value after bet a-2 agonist inhalation ( Salbutamol - 2 puff)]. 4. Symptoms according to Charak Samhita Adhyay 17/56-62 (4 essential + any >=2 other symptoms mention bellow)

Exclusion criteria

Exclusion criteria: Age below 18 year and above 60 year. 2. Moderate persistent, severe persistent asthma. 3. Dyspnoea due to other disease like- LVF, COPD, Upper respiratory tract obstruction, Bronchiectasis, Tuberculosis, Interstitial lung disease, Tropical pulmonary eosinophilia etc. 4. Uncontrolled diabetes mellitus, hypertension and any other systemic disorders. 5. Pregnant or lactating mother

Design outcomes

Primary

Measure	Time frame
objective parameters: PEFR, Eosinophils count, spirometry, Total lung capacity before and after treatmentTimepoint: 2 months	—

Secondary

Measure	Time frame
shows improvement in objective parameters such as PEFR, Eosinophils count, spirometry, Total lung capacity after treatmentTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDR Sarita Kumari

Parul university

dr.shaileshd@gmail.com9763104451

Outcome results